CCケモカイン受容体5型の世界市場レポート 2025年

CCケモカイン受容体5型市場規模は、今後数年で急成長が見込まれます。2029年には22億7,000万米ドルまで成長し、CAGRは10.1％となります。予測期間の成長は、HIVまたはAIDSの蔓延、医療インフラ、経済的インセンティブ、医療需要の増加、経済成長に起因すると考えられます。予測期間における主な動向としては、がん治療に関する研究開発の拡大、併用療法の開発、医薬品製造の開発、戦略的提携やパートナーシップ、臨床試験の拡大などが挙げられます。

慢性疾患の有病率の増加は、今後数年間におけるCCケモカイン受容体5型（CCR5）市場の拡大を牽引すると予想されます。慢性疾患は、心臓病、糖尿病、関節炎などの長期的な病状で、徐々に進行し、一般的に継続的な管理を必要とします。慢性疾患の増加は、人口の高齢化と、食生活の乱れ、運動不足、肥満などのライフスタイルに関連した危険因子の増加によるものです。CCR5は、ヒト免疫不全ウイルス（HIV）のような慢性疾患において重要な役割を果たしており、免疫細胞へのウイルスの侵入を促進し、疾患の進行に寄与するコアセプターとして作用します。例えば、2023年10月、スイスを拠点とするHIV予防に焦点を当てた世界的イニシアティブである国連合同エイズ計画（Joint United Nations Programme on HIV/AIDS）は、2021年には約3,870万人がHIVとともに生き、その数は2022年には3,900万人に増加し、その中には同年の新規感染者130万人も含まれると報告しました。その結果、慢性疾患の有病率の増加がCCR5市場の成長に拍車をかけています。

CCR5市場の企業は競争力を維持するため、CCR5拮抗薬などの新薬開発に注力しています。CCR5拮抗薬は、免疫細胞上のCCR5レセプターをブロックし、HIVのような特定の病原体がこれらの細胞に結合して侵入するのを防ぐことで、感染を抑制し、免疫反応に影響を与える薬剤です。例えば、2024年2月、米国のバイオテクノロジー企業であるCytoDyn Inc.は、米国食品医薬品局（FDA）がPRO140としても知られるCCR5拮抗薬leronlimabの臨床保留を解除したと発表しました。この承認により、CytoDyn社は慢性炎症に対するレロンリマブの効果を評価するために計画していた臨床試験を進めることができます。レロンリマブは、複数の疾患を標的とすることができるため、HIVやがんを含む様々な健康状態を治療する可能性を示しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界CCケモカイン受容体5型PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のCCケモカイン受容体5型市場：成長率分析
• 世界のCCケモカイン受容体5型市場の実績：規模と成長, 2019-2024
• 世界のCCケモカイン受容体5型市場の予測：規模と成長, 2024-2029, 2034F
• 世界CCケモカイン受容体5型総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のCCケモカイン受容体5型市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• BMS-813160
• AG-1105
• CCL-14
• DS-001
• その他のタイプ
• 世界のCCケモカイン受容体5型市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• オンライン薬局
• 小売薬局
• 世界のCCケモカイン受容体5型市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 胃腸
• 免疫学
• 腫瘍学
• その他の用途
• 世界のCCケモカイン受容体5型市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 調査機関
• 製薬会社
• ヘルスケア施設
• 世界のCCケモカイン受容体5型市場BMS-813160のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• HIV治療のためのCCR5拮抗薬
• 炎症性疾患に対するCCR5拮抗薬
• 世界のCCケモカイン受容体5型市場AG-1105のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自己免疫疾患に対するCCR5拮抗薬
• がん治療におけるCCR5拮抗薬
• 世界のCCケモカイン受容体5型市場CCL-14のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標的療法のためのケモカインリガンド
• 免疫調節のためのCCL-14
• 世界のCCケモカイン受容体5型市場DS-001のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん治療におけるCCR5阻害剤
• DS-001炎症性疾患管理用
• 世界のCCケモカイン受容体5型市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 新規CCR5拮抗薬
• 二重標的CCR5拮抗薬

第7章 地域別・国別分析

• 世界のCCケモカイン受容体5型市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のCCケモカイン受容体5型市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• CCケモカイン受容体5型市場：競合情勢
• CCケモカイン受容体5型市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sorrento Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Avexa Limited
• Thermo Fisher Scientific Inc.
• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical
• Gilead Sciences Inc.
• Vertex Pharmaceuticals
• Ono Pharmaceutical Co Ltd
• Abcam Limited
• BioLegend Inc.
• R&D Systems Inc
• American Gene Technologies International Inc
• NSJ Bioreagents
• Cytodyn Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• CCケモカイン受容体5型市場2029：新たな機会を提供する国
• CCケモカイン受容体5型市場2029：新たな機会を提供するセグメント
• CCケモカイン受容体5型市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

CC chemokine receptor type 5 (CCR5) is a protein found on the surface of white blood cells that plays a crucial role in the immune system by serving as a receptor for specific chemokines. These signaling molecules guide the movement of immune cells to areas of inflammation or infection. CCR5 is notably involved in the pathogenesis of diseases such as HIV, where it acts as a co-receptor, enabling the virus to enter and infect host cells, thus making it a target for therapeutic interventions.

The main types of CCR5-related compounds include BMS-813160, AG-1105, CCL-14, DS-001, and others. BMS-813160 is a small-molecule inhibitor developed by Bristol-Myers Squibb, designed to target specific receptors or pathways and is often investigated for its potential therapeutic effects in diseases such as cancer. Distribution channels for these compounds include hospitals, clinics, online pharmacies, and retail pharmacies. They are applied in various fields, including infectious diseases, gastrointestinal conditions, immunology, and oncology, and are used by different end-users such as research institutes, pharmaceutical companies, and healthcare facilities.

The CC chemokine receptor type 5 market research report is one of a series of new reports from The Business Research Company that provides CC chemokine receptor type 5 market statistics, including CC chemokine receptor type 5 industry global market size, regional shares, competitors with an CC chemokine receptor type 5 market share, detailed CC chemokine receptor type 5 market segments, market trends, and opportunities, and any further data you may need to thrive in the CC chemokine receptor type 5 industry. This CC chemokine receptor type 5 market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The CC chemokine receptor type 5 market size has grown rapidly in recent years. It will grow from $1.4 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to government funding, R&D collaborations, public health campaigns, public-private partnerships, and the discovery of CCR5.

The CC chemokine receptor type 5 market size is expected to see rapid growth in the next few years. It will grow to $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to the prevalence of HIV or AIDS, healthcare infrastructure, economic incentives, increasing demand for healthcare, and economic growth. Major trends in the forecast period include expanding research on cancer treatment, development of combination therapies, development of pharmaceutical manufacturing, strategic collaborations and partnerships, and clinical trials expansion.

The growing prevalence of chronic diseases is expected to drive the expansion of the CC chemokine receptor type 5 (CCR5) market in the coming years. Chronic diseases are long-term medical conditions, such as heart disease, diabetes, and arthritis, which progress gradually and typically require ongoing management. The rise in chronic diseases can be attributed to aging populations and increasing rates of lifestyle-related risk factors, including poor diet, lack of physical activity, and obesity. CCR5 plays a key role in chronic diseases like human immunodeficiency virus (HIV), acting as a coreceptor that facilitates the virus's entry into immune cells and contributes to the disease's progression. For example, in October 2023, the Joint United Nations Programme on HIV/AIDS, a Switzerland-based global initiative focused on HIV prevention, reported that in 2021, approximately 38.7 million people were living with HIV, with the number rising to 39.0 million in 2022, including 1.3 million new infections that year. Consequently, the increasing prevalence of chronic diseases is fueling the growth of the CCR5 market.

Companies in the CCR5 market are focusing on developing new drugs, such as CCR5 antagonists, to maintain a competitive edge. CCR5 antagonists are medications that block the CCR5 receptor on immune cells, preventing certain pathogens such as HIV from binding and entering these cells, thereby inhibiting infection and influencing immune responses. For instance, in February 2024, CytoDyn Inc., a US-based biotechnology firm, announced that the U.S. Food and Drug Administration (FDA) had lifted the clinical hold on leronlimab, a CCR5 antagonist also known as PRO 140. This approval allows CytoDyn to proceed with its planned clinical trial to evaluate leronlimab's effects on chronic inflammation. Leronlimab shows potential for treating various health conditions, including HIV and cancer, due to its ability to target multiple diseases.

In October 2022, Amgen Inc., a US-based biopharmaceutical company, acquired ChemoCentryx for approximately $3.7 billion. This acquisition is aimed at enhancing Amgen's portfolio in inflammation and nephrology by incorporating ChemoCentryx's innovative therapeutics, such as TAVNEOS (avacopan), into its product lineup. ChemoCentryx is a US-based company specializing in CCR5-related medicines.

Major companies operating in the cc chemokine receptor type 5 market are Pfizer Inc., Sorrento Therapeutics, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Avexa Limited, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical, Gilead Sciences Inc., Vertex Pharmaceuticals, Ono Pharmaceutical Co Ltd, Abcam Limited, BioLegend Inc., R&D Systems Inc, American Gene Technologies International Inc, NSJ Bioreagents, Cytodyn Inc., Affinity Biosciences

North America was the largest region in the CC chemokine receptor type 5 market in 2024. The regions covered in the cc chemokine receptor type 5 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cc chemokine receptor type 5 market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The CC chemokine receptor type 5 market consists of sales of receptor antagonists, monoclonal antibodies, small molecule inhibitors, and gene editing therapies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

CC Chemokine Receptor Type 5 Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cc chemokine receptor type 5 market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cc chemokine receptor type 5 ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cc chemokine receptor type 5 market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: BMS-813160; AG-1105; CCL-14; DS-001; Other Types
• 2) By Distribution Channel: Hospitals; Clinics; Online Pharmacies; Retail Pharmacies
• 3) By Application: Infectious Disease; Gastrointestinal; Immunology; Oncology; Other Applications
• 4) By End User: Research Institutes; Pharmaceutical Companies; Healthcare Facilities
• Subsegments:
• 1) By BMS-813160: CCR5 Antagonist For HIV Treatment; CCR5 Antagonist For Inflammatory Diseases
• 2) By AG-1105: CCR5 Antagonist For Autoimmune Disorders; CCR5 Antagonist For Cancer Therapy
• 3) By CCL-14: Chemokine Ligand For Targeted Therapy; CCL-14 For Immune Modulation
• 4) By DS-001: CCR5 Inhibitor For Cancer Treatment; DS-001 For Inflammatory Disease Management
• 5) By Other Types: Novel CCR5 Antagonists; Dual-Target CCR5 Antagonists
• Companies Mentioned: Pfizer Inc.; Sorrento Therapeutics; Merck & Co. Inc.; AbbVie Inc.; Sanofi SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. CC Chemokine Receptor Type 5 Market Characteristics

3. CC Chemokine Receptor Type 5 Market Trends And Strategies

4. CC Chemokine Receptor Type 5 Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global CC Chemokine Receptor Type 5 Growth Analysis And Strategic Analysis Framework

• 5.1. Global CC Chemokine Receptor Type 5 PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global CC Chemokine Receptor Type 5 Market Growth Rate Analysis
• 5.4. Global CC Chemokine Receptor Type 5 Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global CC Chemokine Receptor Type 5 Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global CC Chemokine Receptor Type 5 Total Addressable Market (TAM)

6. CC Chemokine Receptor Type 5 Market Segmentation

• 6.1. Global CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• BMS-813160
• AG-1105
• CCL-14
• DS-001
• Other Types
• 6.2. Global CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Online Pharmacies
• Retail Pharmacies
• 6.3. Global CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease
• Gastrointestinal
• Immunology
• Oncology
• Other Applications
• 6.4. Global CC Chemokine Receptor Type 5 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Institutes
• Pharmaceutical Companies
• Healthcare Facilities
• 6.5. Global CC Chemokine Receptor Type 5 Market, Sub-Segmentation Of BMS-813160, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CCR5 Antagonist For HIV Treatment
• CCR5 Antagonist For Inflammatory Diseases
• 6.6. Global CC Chemokine Receptor Type 5 Market, Sub-Segmentation Of AG-1105, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CCR5 Antagonist For Autoimmune Disorders
• CCR5 Antagonist For Cancer Therapy
• 6.7. Global CC Chemokine Receptor Type 5 Market, Sub-Segmentation Of CCL-14, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemokine Ligand For Targeted Therapy
• CCL-14 For Immune Modulation
• 6.8. Global CC Chemokine Receptor Type 5 Market, Sub-Segmentation Of DS-001, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CCR5 Inhibitor For Cancer Treatment
• DS-001 For Inflammatory Disease Management
• 6.9. Global CC Chemokine Receptor Type 5 Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Novel CCR5 Antagonists
• Dual-Target CCR5 Antagonists

7. CC Chemokine Receptor Type 5 Market Regional And Country Analysis

• 7.1. Global CC Chemokine Receptor Type 5 Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global CC Chemokine Receptor Type 5 Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific CC Chemokine Receptor Type 5 Market

• 8.1. Asia-Pacific CC Chemokine Receptor Type 5 Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China CC Chemokine Receptor Type 5 Market

• 9.1. China CC Chemokine Receptor Type 5 Market Overview
• 9.2. China CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India CC Chemokine Receptor Type 5 Market

• 10.1. India CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan CC Chemokine Receptor Type 5 Market

• 11.1. Japan CC Chemokine Receptor Type 5 Market Overview
• 11.2. Japan CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia CC Chemokine Receptor Type 5 Market

• 12.1. Australia CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia CC Chemokine Receptor Type 5 Market

• 13.1. Indonesia CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea CC Chemokine Receptor Type 5 Market

• 14.1. South Korea CC Chemokine Receptor Type 5 Market Overview
• 14.2. South Korea CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe CC Chemokine Receptor Type 5 Market

• 15.1. Western Europe CC Chemokine Receptor Type 5 Market Overview
• 15.2. Western Europe CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK CC Chemokine Receptor Type 5 Market

• 16.1. UK CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany CC Chemokine Receptor Type 5 Market

• 17.1. Germany CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France CC Chemokine Receptor Type 5 Market

• 18.1. France CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy CC Chemokine Receptor Type 5 Market

• 19.1. Italy CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain CC Chemokine Receptor Type 5 Market

• 20.1. Spain CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe CC Chemokine Receptor Type 5 Market

• 21.1. Eastern Europe CC Chemokine Receptor Type 5 Market Overview
• 21.2. Eastern Europe CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia CC Chemokine Receptor Type 5 Market

• 22.1. Russia CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America CC Chemokine Receptor Type 5 Market

• 23.1. North America CC Chemokine Receptor Type 5 Market Overview
• 23.2. North America CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA CC Chemokine Receptor Type 5 Market

• 24.1. USA CC Chemokine Receptor Type 5 Market Overview
• 24.2. USA CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada CC Chemokine Receptor Type 5 Market

• 25.1. Canada CC Chemokine Receptor Type 5 Market Overview
• 25.2. Canada CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America CC Chemokine Receptor Type 5 Market

• 26.1. South America CC Chemokine Receptor Type 5 Market Overview
• 26.2. South America CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil CC Chemokine Receptor Type 5 Market

• 27.1. Brazil CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East CC Chemokine Receptor Type 5 Market

• 28.1. Middle East CC Chemokine Receptor Type 5 Market Overview
• 28.2. Middle East CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa CC Chemokine Receptor Type 5 Market

• 29.1. Africa CC Chemokine Receptor Type 5 Market Overview
• 29.2. Africa CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. CC Chemokine Receptor Type 5 Market Competitive Landscape And Company Profiles

• 30.1. CC Chemokine Receptor Type 5 Market Competitive Landscape
• 30.2. CC Chemokine Receptor Type 5 Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sorrento Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. CC Chemokine Receptor Type 5 Market Other Major And Innovative Companies

• 31.1. Avexa Limited
• 31.2. Thermo Fisher Scientific Inc.
• 31.3. AstraZeneca plc
• 31.4. Novartis AG
• 31.5. GlaxoSmithKline plc
• 31.6. Takeda Pharmaceutical
• 31.7. Gilead Sciences Inc.
• 31.8. Vertex Pharmaceuticals
• 31.9. Ono Pharmaceutical Co Ltd
• 31.10. Abcam Limited
• 31.11. BioLegend Inc.
• 31.12. R&D Systems Inc
• 31.13. American Gene Technologies International Inc
• 31.14. NSJ Bioreagents
• 31.15. Cytodyn Inc.

32. Global CC Chemokine Receptor Type 5 Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The CC Chemokine Receptor Type 5 Market

34. Recent Developments In The CC Chemokine Receptor Type 5 Market

35. CC Chemokine Receptor Type 5 Market High Potential Countries, Segments and Strategies

• 35.1 CC Chemokine Receptor Type 5 Market In 2029 - Countries Offering Most New Opportunities
• 35.2 CC Chemokine Receptor Type 5 Market In 2029 - Segments Offering Most New Opportunities
• 35.3 CC Chemokine Receptor Type 5 Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer